Please login to the form below

Not currently logged in
Email:
Password:

Quintiles acquires US CRO Novella Clinical

Deal will boost its small biopharma, oncology and medical device capabilities

Pharmaceutical services company Quintiles has bolstered its contract research capabilities with the acquisition of Novella Clinical for an undisclosed amount.

The US-headquartered contract research organisation (CRO) has more than 800 employees across North America and Europe and focuses on oncology, medical devices and diagnostics sectors

Quintiles, which said the deal would help it stay ahead of the diverse and evolving needs of its global customer base, also expects a boost for its small biopharma capabilities.

Paula Brown Stafford, president, clinical development at Quintiles, said: “The expertise and insight the Novella team brings will be a strong addition to our existing capabilities and help further differentiate Quintiles in an increasingly competitive marketplace.

“Novella's understanding of emerging companies, as well as our shared commitment to quality, customer service, and above all, the patients we ultimately serve, makes this acquisition a good fit for both organisations.”

Founded 15 years ago, Novella is a full-service CRO whose offerings include clinical monitoring, data management, regulatory affairs, qualify assurance and safety management.

Once the acquisition is completed Novella will operate as a standalone unit within Quintiles under its existing name.

23rd August 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics